Crossmark

Nano-engineered monoclonal antibodies expanding the newer avenues for cancer targeting

Published Online: 2024-09-20

Published Print: 2025-02

Authors

Janakiraman, Kumar

Jayaraj, Gracesuganthi

Sethuraman, Vaidevi

Krishnaswami, Venkateshwaran
License Information

Text and Data Mining valid from 2024-09-20

Version of Record valid from 2024-09-20
More Information

Article History

Received: 24 June 2024

Revised: 28 August 2024

Accepted: 2 September 2024

First Online: 20 September 2024

Declarations

:

: The authors affirm that there are no conflicting interests.

: Not applicable.

: Not applicable.

: Not applicable.

Document is current